Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 6, 2001, Pages 537-546

  Petrovich, Zbigniew ^a   Lieskovsky, Gary ^a   Langholz, Bryan ^a   Huberman, Mark ^a   Streeter, O Oscar ^a   Skinner, Donald G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adjuvant radiotherapy; Prostate cancer; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PELVIS; PREOPERATIVE EVALUATION; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; REGRESSION ANALYSIS; RISK FACTOR; SCORING SYSTEM;

ADENOCARCINOMA; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 0035209470     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200112000-00002     Document Type: Article

References (31)

1. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy
2. Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy
3. Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade and margins of resection to prognosis
4. Incidence and significance of positive margins in radical prostatectomy specimens
5. Prognostic significance of positive surgical margins in radical prostatectomy specimens
6. Extended follow-up of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation
7. Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: Selecting the patient for adjuvant therapy
8. Disease progression following radical prostatectomy in men with Gleason score 7 tumor
9. When should radiation therapy follow radical prostatectomy in the management of prostatic cancer?
10. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: Analysis of freedom from PSA failure
11. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer
12. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: Improved local control
13. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate
14. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy
15. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: Ten-year update
16. Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate
17. Prostate
18. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCN0) prostate cancer from 1976 to 1989: Intermediate findings
19. Non-parametric estimation from incomplete observations
20. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
21. Nonparametric confidence limits for survival probabilities and median survival time
22. Regression models and life-tables
23. A large sample study of the estimates for the integrated hazard function in Cox's regression model for survival data
24. Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome
25. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy
26. Dose-response relationship for radiation therapy of subclinical disease
27. Radiation dose response for subclinical disease
28. A standard dose of radiation for "microscopic disease" is not appropriate
29. Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy
30. Long-term impact of moderate dose of postoperative radiation on urinary continence and sexual potency in prostate cancer
31. Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome